| 12 |
Cross-species transmission of the newly identified coronavirus 2019-nCoV
Ji, W.
Vol. 92 pp. 433-440
|
2020 |
611
|
| 28 |
Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection
Chiba Y, Higashidate Y, Suga K, Honjo K, Tsutsumi H, Ogra PL, ,
Vol. 28 pp. -
|
1989 |
423
|
| 26 |
Reinfection of mice with respiratory syncytial virus
Graham BS, Bunton LA, Wright PF, Karzon DT, ,
Vol. 34 pp. -
|
1991 |
409
|
| 35 |
Viral load in patients infected with pandemic H1N1 2009 influenza A virus
To KK, Chan KH, Li IW, Tsang TY, Tse H, Chan JF, Hung IF, Lai ST, Leung CW, Kwan YW, Lau YL, Ng TK, Cheng VC, Peiris JS, Yuen KY, ,
Vol. 82 pp. -
|
2010 |
406
|
| 27 |
Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections
Cranage MP, Gardner PS, ,
Vol. 5 pp. -
|
1980 |
340
|
| 1 |
Prevalence and genetic diversity of human sapovirus associated with sporadic acute gastroenteritis in South China from 2013 to 2017.
Xue, Liang, Cai, Weicheng, Zhang, Le, Gao, Junshan, Dong, Ruimin, Li, Yonglai, Wu, Haoming, Zhang, Jumei, Zeng, Haiyan, Ye, Qinghua, Ding, Yu, Wu, Qingping,
|
2019 |
335
|
| 5 |
Clinical and Th1/Th2 Immune Response Features of Hospitalized Children with Human Rhinovirus Infection.
Yuan, Xin-Hui, Li, Yu-Mei, Shen, Yi-Yi, Yang, Jin, Jin, Yu,
|
2019 |
331
|
| 17 |
Positive Externalities of an Epidemic: The Case of the Corona Virus (COVID-19) in China.
Okyere, Michael Adu, Forson, Richmond, Essel-Gaisey, Felix,
|
2020 |
325
|
| 9 |
Potential interventions for novel coronavirus in China: A systematic review.
Zhang, Lei, Liu, Yunhui,
Vol. 92 pp. 479-490
|
2020 |
320
|
| 31 |
Local antibody production and respiratory syncytial virus infection in children with leukaemia
Taylor CE, Craft AW, Kernahan J, Millman R, Reid MM, Scott R, Toms GL, ,
Vol. 30 pp. -
|
1990 |
303
|
| 30 |
Experimental respiratory syncytial virus pneumonia in cebus monkeys
Richardson LS, Belshe RB, Sly DL, London WT, Prevar DA, Camargo E, Chanock RM, ,
Vol. 2 pp. -
|
1978 |
292
|
| 11 |
Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.
Lu, Shubiao, Lin, Jinsong, Zhang, Zhiqiao, Xiao, Liping, Jiang, Zhijian, Chen, Jia, Hu, Chongjing, Luo, Shi,
|
2020 |
288
|
| 2 |
Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform
Thepbundit, V.
Vol. 91 pp. 1652-1659
|
2019 |
286
|
| 3 |
Reconnaissance of the candidate genes involved in the pathogenesis of human immunodeficiency virus and targeted by antiretroviral therapy.
Mozhgani, Sayed-Hamidreza, Zarei Ghobadi, Mohadeseh, Behnam Rad, Mohammad, Farzanehpour, Mahdieh, Behzadian, Farida,
|
2019 |
273
|
| 8 |
Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19.
Qu, Rong, Ling, Yun, Zhang, Yi-Huizhi, Wei, Li-Ya, Chen, Xiao, Li, Xumian, Liu, Xuan-Yong, Liu, Han-Mian, Guo, Zhi, Ren, Hua, Wang, Qiang,
|
2020 |
262
|
| 18 |
Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".
Sun, Pengfei, Ren, Jizhen, Li, Kun, Qie, Shuyan, Liu, Zongjian, Xi, Jianing,
|
2020 |
259
|
| 16 |
The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): well-mixed SEIR model analysis.
Hou, Can, Chen, Jiaxin, Zhou, Yaqing, Hua, Lei, Yuan, Jinxia, He, Shu, Guo, Yi, Zhang, Sheng, Jia, Qiaowei, Zhao, Chenhui, Zhang, Jing, Xu, Guangxu, Jia, Enzhi,
|
2020 |
251
|
| 36 |
The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients
Li YC, Bai WZ, Hashikawa T, ,
Vol. 92 pp. -
|
2020 |
251
|
| 19 |
CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19).
Sun, Pengfei, Lu, Xiaosheng, Xu, Chao, Wang, Yanjin, Sun, Wenjuan, Xi, Jianing,
|
2020 |
241
|
| 7 |
Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses
Elfiky, A.
Vol. 89 pp. 1040-1047
|
2017 |
232
|
